We are live on ! Find out more
AI

Atria Investments Portfolio holdings

AUM $9.98B
1-Year Est. Return 26.5%
This Fund
S&P 500
This Quarter Est. Return
+9.97%
1 Year Est. Return
+26.5%
3 Year Est. Return
+76.3%
5 Year Est. Return
+88.62%
10 Year Est. Return
+324.13%
AUM
$8.47B
AUM Growth
+$667M
Cap. Flow
+$51.8M
Cap. Flow %
0.61%
Top 10 Hldgs %
13.2%
Holding
2,101
New
211
Increased
943
Reduced
821
Closed
119
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIRR icon
876
First Trust RBA American Industrial Renaissance ETF
AIRR
$10.7B
$1.42M 0.02%
17,448
-26,299
-60% -$1.94M
SHYM
877
iShares Short Duration High Yield Muni Active ETF
SHYM
$814M
$1.42M 0.02%
63,534
-123,135
-66% -$2.73M
FTI icon
878
TechnipFMC
FTI
$29.1B
$1.41M 0.02%
41,047
-2,635
-6% -$79.5K
EQR icon
879
Equity Residential
EQR
$24.7B
$1.41M 0.02%
20,925
-836
-4% -$57.5K
EMBJ
880
Embraer S.A. ADS
EMBJ
$13.1B
$1.41M 0.02%
24,806
+1,866
+8% +$88.1K
MDY icon
881
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$1.41M 0.02%
2,488
+269
+12% +$144K
FRT icon
882
Federal Realty Investment Trust
FRT
$10.2B
$1.41M 0.02%
+14,818
New +$1.4M
UNF icon
883
Unifirst Corp
UNF
$5.24B
$1.4M 0.02%
7,461
+800
+12% +$145K
AXTA icon
884
Axalta
AXTA
$8.01B
$1.4M 0.02%
47,253
-7,682
-14% -$239K
TTAN
885
ServiceTitan Inc
TTAN
$8.29B
$1.4M 0.02%
+13,023
New +$1.46M
ALNY icon
886
Alnylam Pharmaceuticals
ALNY
$29B
$1.39M 0.02%
4,276
+72
+2% +$19.9K
PHM icon
887
Pultegroup
PHM
$24.8B
$1.39M 0.02%
13,205
-2,139
-14% -$216K
FXO icon
888
First Trust Financials AlphaDEX Fund
FXO
$1.14B
$1.39M 0.02%
24,814
-243
-1% -$12.7K
SBAC icon
889
SBA Communications
SBAC
$19.2B
$1.39M 0.02%
5,907
+1,705
+41% +$390K
EMN icon
890
Eastman Chemical
EMN
$8.39B
$1.38M 0.02%
18,524
-7,193
-28% -$565K
IWB icon
891
iShares Russell 1000 ETF
IWB
$50.2B
$1.38M 0.02%
4,073
+36
+0.9% +$11.3K
HOLX
892
DELISTED
Hologic
HOLX
$1.38M 0.02%
21,221
-1,773
-8% -$106K
ICLN icon
893
iShares Global Clean Energy ETF
ICLN
$2.08B
$1.38M 0.02%
+105,285
New +$1.29M
AOS icon
894
A.O. Smith
AOS
$8.48B
$1.38M 0.02%
21,023
-6,326
-23% -$414K
EW icon
895
Edwards Lifesciences
EW
$53B
$1.38M 0.02%
17,616
-1,775
-9% -$132K
JIVE icon
896
JPMorgan International Value ETF
JIVE
$3.61B
$1.37M 0.02%
19,808
-605
-3% -$38.9K
BAH icon
897
Booz Allen Hamilton
BAH
$9.37B
$1.37M 0.02%
13,153
-586
-4% -$65.6K
ARKW icon
898
ARK Web x.0 ETF
ARKW
$1.77B
$1.37M 0.02%
9,253
-1,009
-10% -$115K
FYC icon
899
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.4B
$1.36M 0.02%
17,133
+11,571
+208% +$831K
VIG icon
900
Vanguard Dividend Appreciation ETF
VIG
$114B
$1.36M 0.02%
6,646
+2,809
+73% +$544K

Similar funds

Atria Investments's Q2 2025 Portfolio in Review

As of Q2 2025, Atria Investments held 2,101 positions worth $8.47B, up 8.5% from $7.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Atria Investments's Q2 2025 filing shows 211 new, 943 increased, 821 reduced and 119 closed positions. Its largest new stake was American Century Diversified Corporate Bond ETF: 958,522 shares worth $45.1M. The largest sale was iShares 0-5 Year High Yield Corporate Bond ETF, an estimated $29.9M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Atria Investments's largest Q2 2025 buy was American Century Diversified Corporate Bond ETF: 958,522 shares worth $45.1M.
  • Atria Investments added most to iShares MSCI EAFE Value ETF in Q2 2025, an estimated $18.4M increase.
  • Atria Investments's biggest Q2 2025 reduction was iShares 0-5 Year High Yield Corporate Bond ETF, cutting an estimated $29.9M.
  • Atria Investments fully exited iShares 20+ Year Treasury Bond BuyWrite Strategy ETF in Q2 2025, selling an estimated $6.29M.
  • Atria Investments's ten largest holdings make up 13% of its $8.47B portfolio in Q2 2025.
  • Atria Investments opened 211 new positions and closed 119 in Q2 2025.
  • Atria Investments's portfolio value rose 8.5% quarter-over-quarter to $8.47B.

Based on Atria Investments's 13F filing for Q2 2025, filed 4 Aug 2025.